Sisu Global Health provides clinically proven, patented, high margin devices, starting with Hemafuse, a highly effective alternative to donor blood. With a simple push and pull of a handle, the device transfers blood from where it is pooled in internal bleeding to a blood bag: blood is salvaged and immediately re-transfused. Sisu achieved regulatory approval in Ghana and Kenya and Hemafuse and signed two distribution contracts. Founded in 2014 by Carolyn Yarina, Gillian Henker, and Katie Kirsch, Sisu Global Health is headquartered in Baltimore, Maryland.

United States

Baltimore, MD, USA

North America

Sisu Global Health

Health

Series A

Better Ventures is a venture capital firm that provides funding and support to companies creating scalable solutions to some of the world's biggest challenges.

Open Opportunities